Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DV8N | ISIN: GB00BMXNWH07 | Ticker-Symbol: 85V1
Tradegate
17.01.25
10:41 Uhr
32,303 Euro
-0,333
-1,02 %
Branche
Öl/Gas
Aktienmarkt
Sonstige
1-Jahres-Chart
NOBLE CORPORATION PLC Chart 1 Jahr
5-Tage-Chart
NOBLE CORPORATION PLC 5-Tage-Chart
RealtimeGeldBriefZeit
32,35033,15018.01.
32,44732,84817.01.
PR Newswire
312 Leser
Artikel bewerten:
(2)

Noble Corporation plc announces approval of request for removal from trading and official listing on Nasdaq Copenhagen

Finanznachrichten News

SUGAR LAND, Texas, Nov. 18, 2024 /PRNewswire/ -- Noble Corporation plc ("Noble", the "Company") (NYSE: NE, CSE: NOBLE) announces that today, Nasdaq Copenhagen A/S ("Nasdaq Copenhagen") has approved Noble's request for the voluntary removal of its shares (in the form of share entitlements) (the "DanishShares") from trading and official listing on Nasdaq Copenhagen (the "Delisting") pursuant to Rule 22(ii) of Supplement A of the Nordic Main Market Rulebook for Issuers of Shares.

The last day of trading on Nasdaq Copenhagen will be December 16, 2024 and the Delisting will be effective on December 17, 2024. Following the Delisting, the Danish Shares will no longer be tradable on Nasdaq Copenhagen.

The Delisting will not affect Noble's listing on the New York Stock Exchange and Noble will remain traded on the New York Stock Exchange as Noble's primary listing exchange.

Possible courses of action for holders of Noble's Danish Shares

In connection with the Delisting, holders of Danish Shares may:

  • Dispose of their Danish Shares on Nasdaq Copenhagen before the Delisting is effective; or
  • Convert their Danish Shares to an equivalent number of Noble shares tradeable on the New York Stock Exchange.

Alternatively, holders of Danish Shares may do nothing but will hold an illiquid asset following the Delisting.

For further information about the Delisting or the options available to holders of Danish Shares, see Noble's announcement of November 14, 2024 regarding the submission of request for removal from trading and official listing on Nasdaq Copenhagen.

Additional information regarding the Delisting can be found on our website: www.noblecorp.com.

About Noble Corporation
Noble is a leading offshore drilling contractor for the oil and gas industry. The Company owns and operates one of the most modern, versatile, and technically advanced fleets in the offshore drilling industry. Noble and its predecessors have been engaged in the contract drilling of oil and gas wells since 1921. Noble performs, through its subsidiaries, contract drilling services with a fleet of offshore drilling units focused largely on ultra-deepwater and high specification jackup drilling opportunities in both established and emerging regions worldwide. For further information visit www.noblecorp.com or email investors@noblecorp.com.

IMPORTANT INFORMATION
This announcement is for information purposes only and does not constitute or contain any invitation, solicitation, recommendation, offer or advice to any person to subscribe for or otherwise acquire or dispose of any securities of Noble.

Certain statements in this announcement, including any attachments hereto, may constitute forward-looking statements. Forward-looking statements are statements (other than statements of historical fact) relating to future events and Noble and its subsidiaries (collectively, the "Noble Group"). The words "targets", "believes", "continues", "expects", "aims", "intends", "plans", "seeks", "will", "may", "might", "anticipates", "would", "could", "should", "estimates", "projects", "potentially" or similar expressions or the negatives thereof, identify certain of these forward-looking statements. The absence of these words, however, does not mean that the statements are not forward-looking. Other forward-looking statements can be identified in the context in which the statements are made.

Although Noble believes that the expectations reflected in these forward-looking statements are reasonable as of the date of this announcement, such forward-looking statements are based on Noble's current expectations, estimates, forecasts, assumptions and projections about the particular events in question.

Any forward-looking statements included in this announcement, including any attachment hereto, speak only as of today. Noble does not intend, and does not assume, any obligations to update any forward-looking statements contained herein, except as may be required by law or the rules of the New York Stock Exchange or Nasdaq Copenhagen. All subsequent written and oral forward-looking statements attributable to Noble or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained in this announcement, including any attachment hereto.

Cision View original content:https://www.prnewswire.co.uk/news-releases/noble-corporation-plc-announces-approval-of-request-for-removal-from-trading-and-official-listing-on-nasdaq-copenhagen-302308750.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.